AA-31-YE07_1uM Gene Set
| Dataset |
NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles
|
| Category |
transcriptomics
|
| Type |
drug perturbation |
| Description |
Dose=1uM, Chrysin, Apoptosis Inducers;Breast Cancer-Resistant Protein (BCRP;Antiinflammatory Drugs;ABCG2) Inhibitors;Antioxidants targeting ABCG2, HSD17B10, HSD17B7, HSD17B2, HSD17B8, HSD17B6, HSD17B12, HSD17B11, HSD17B14, HSD17B13 (Novartis, 5281607)
|
| External Link |
https://pubchem.ncbi.nlm.nih.gov/compound/5281607
|
| Similar Terms |
|
| Downloads & Tools |
|
Genes
12 genes differentially expressed following the AA-31-YE07_1uM drug perturbation from the NIBR DRUG-seq U2OS MoA Box dataset.
increased expression
| Symbol |
Name |
Standardized Value |
|
SELENOW
|
selenoprotein W
|
0.621307
|
|
TMSB10
|
thymosin beta 10
|
0.46483
|
|
MT1E
|
metallothionein 1E
|
0.46483
|
|
C11ORF24
|
chromosome 11 open reading frame 24
|
0.257415
|
|
SLC25A21
|
solute carrier family 25 (mitochondrial oxoadipate carrier), member 21
|
0.247318
|
|
RPS2
|
ribosomal protein S2
|
0.225882
|
|
CSRP1
|
cysteine and glycine-rich protein 1
|
0.213133
|
decreased expression
| Symbol |
Name |
Standardized Value |
|
MAGED1
|
melanoma antigen family D1
|
-0.621307
|
|
LAMTOR4
|
late endosomal/lysosomal adaptor, MAPK and MTOR activator 4
|
-0.257415
|
|
CCT7
|
chaperonin containing TCP1, subunit 7 (eta)
|
-0.24846
|
|
RPS28
|
ribosomal protein S28
|
-0.215192
|
|
RPS3
|
ribosomal protein S3
|
-0.200641
|